Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Otorhinolaryngology

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 121 articles: HTML format

Single Articles

May 2021
1. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
   Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
   Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
   PubMed     Abstract available
   
   
   April 2021
2. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
   Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
   Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
   PubMed     Abstract available
   
   
   March 2021
3. NARUSAKA T, Ohara T, Noma K, Nishiwaki N, et al
   Nanog is a promising chemo-resistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
   Int J Cancer. 2021 Mar 4. doi: 10.1002/ijc.33544.
   PubMed     Abstract available
   
   
   December 2020
4. VON WITZLEBEN A, Fehn A, Grages A, EziC J, et al
   Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC).
   Int J Cancer. 2020 Dec 17. doi: 10.1002/ijc.33446.
   PubMed     Abstract available
   
   
   
5. GETZ KR, Bellile E, Zarins KR, Rullman C, et al
   Statin Use and Head and Neck Squamous Cell Carcinoma Outcomes.
   Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33441.
   PubMed     Abstract available
   
   
   
6. MMBAGA BT, Mwasamwaja A, Mushi G, Mremi A, et al
   Missing and Decayed Teeth, Oral Hygiene and Dental Staining in relation to Esophageal Cancer Risk: ESCCAPE case-control study in Kilimanjaro Tanzania.
   Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33433.
   PubMed     Abstract available
   
   
   
7. CHEN GH, Liu Z, Ji MF, Pfeiffer RM, et al
   Prospective Assessment of a Nasopharyngeal Carcinoma Risk Score in a Population Undergoing Screening.
   Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33424.
   PubMed     Abstract available
   
   
   
8. YANG CS, Chen XL
   Research on esophageal cancer: with personal perspectives from studies in China and Kenya.
   Int J Cancer. 2020 Dec 3. doi: 10.1002/ijc.33421.
   PubMed     Abstract available
   
   
   November 2020
9. SONG L, Zhang S, Yu S, Ma F, et al
   Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
   Int J Cancer. 2020;147:2879-2890.
   PubMed     Abstract available
   
   
   October 2020
10. BUCKLE GC
    Esophageal sponge sampling: a promising approach for early detection of esophageal cancer in Africa's high-incidence region.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33372.
    PubMed    
    
    
    September 2020
11. ZHANG J, Luo X, Huang Q, Huang Y, et al
    Clinicopathological and Prognostic Features of Nasopharyngeal Carcinoma in Children and Adolescents: A Retrospective Study of 196 Cases in South China.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33293.
    PubMed     Abstract available
    
    
    
12. BUCKLE GC, Mahapatra R, Mwachiro M, Akoko L, et al
    Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33299.
    PubMed     Abstract available
    
    
    
13. PLATH M, Gass J, Hlevnjak M, Li Q, et al
    Unraveling most abundant mutational signatures in head and neck cancer.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33297.
    PubMed     Abstract available
    
    
    
14. MOHEBBI E, Hadji M, Rashidian H, Rezaianzadeh A, et al
    Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33289.
    PubMed     Abstract available
    
    
    
15. TANAKA H, Takemoto N, Horie M, Takai E, et al
    Circulating Tumor HPV DNA Complements PET-CT in Guiding Management after Radiotherapy in HPV-Related Squamous Cell Carcinoma of the Head and Neck.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33287.
    PubMed     Abstract available
    
    
    August 2020
16. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    PubMed     Abstract available
    
    
    
17. DALMARTELLO M, Decarli A, Ferraroni M, Bravi F, et al
    Dietary patterns and oral and pharyngeal cancer using latent class analysis.
    Int J Cancer. 2020;147:719-727.
    PubMed     Abstract available
    
    
    July 2020
18. CHEN W, Li H, Ren J, Zheng R, et al
    Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Int J Cancer. 2020 Jul 14. doi: 10.1002/ijc.33208.
    PubMed     Abstract available
    
    
    June 2020
19. HU Y, Zhang X, Wang O, Bi Y, et al
    The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33166.
    PubMed     Abstract available
    
    
    
20. FACOMPRE ND, Rajagopalan P, Sahu V, Pearson AT, et al
    Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Int J Cancer. 2020 Jun 1. doi: 10.1002/ijc.33125.
    PubMed     Abstract available
    
    
    May 2020
21. TAY JK, Siow CH, Goh HL, Lim CM, et al
    A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Int J Cancer. 2020;146:2923-2931.
    PubMed     Abstract available
    
    
    April 2020
22. REN J, Xu W, Su J, Ren X, et al
    Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
    Int J Cancer. 2020;146:2166-2174.
    PubMed     Abstract available
    
    
    
23. SIMON J, Schroeder L, Ingarfield K, Diehl S, et al
    Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Int J Cancer. 2020 Apr 12. doi: 10.1002/ijc.33006.
    PubMed     Abstract available
    
    
    March 2020
24. TIAN W, Zhu F, Cai J, Li L, et al
    Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma (NPC) patients in Hunan province, southern China.
    Int J Cancer. 2020 Mar 24. doi: 10.1002/ijc.32992.
    PubMed     Abstract available
    
    
    
25. ESSERS PBM, van der Heijden M, Vossen D, de Roest RH, et al
    Ovarian cancer derived copy number alterations signatures are prognostic in chemoradiotherapy treated head and neck squamous cell carcinoma.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32962.
    PubMed     Abstract available
    
    
    February 2020
26. ZSCHAECK S, Li Y, Butof R, Lili C, et al
    Combined tumor plus non-tumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancer.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32897.
    PubMed     Abstract available
    
    
    January 2020
27. NAKAGAWA T, Matsusaka K, Misawa K, Ota S, et al
    Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
    Int J Cancer. 2020 Jan 30. doi: 10.1002/ijc.32890.
    PubMed     Abstract available
    
    
    
28. MASTERSON L, Howard J, Gonzalez-Cruz J, Jackson C, et al
    Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: beyond an era of chemoradiation?
    Int J Cancer. 2020 Jan 17. doi: 10.1002/ijc.32869.
    PubMed     Abstract available
    
    
    December 2019
29. SU TH, Tseng TC, Liu CJ, Chou SW, et al
    Antiviral Therapy against Chronic Hepatitis C is Associated with a Reduced Risk of Oral Cancer.
    Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32840.
    PubMed     Abstract available
    
    
    
30. PALACIOS-GARCIA J, Sanz-Flores M, Asensio A, Alvarado R, et al
    G-protein coupled receptor kinase 2 safeguards epithelial phenotype in Head and Neck Squamous Cell Carcinomas.
    Int J Cancer. 2019 Dec 18. doi: 10.1002/ijc.32838.
    PubMed     Abstract available
    
    
    
31. WILKAT M, Bast H, Drees R, Dunser J, et al
    Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.
    Int J Cancer. 2019 Dec 17. doi: 10.1002/ijc.32835.
    PubMed     Abstract available
    
    
    
32. CHANG CP, Siwakoti B, Sapkota A, Gautam DK, et al
    Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32823.
    PubMed     Abstract available
    
    
    November 2019
33. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.
    PubMed    
    
    
    
34. LEHTINEN M, Apter D, Eriksson T, Harjula K, et al
    Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females - results from a community-randomized trial.
    Int J Cancer. 2019 Nov 17. doi: 10.1002/ijc.32791.
    PubMed     Abstract available
    
    
    
35. RYAN N, Anderson K, Volpedo G, Hamza O, et al
    STAT1 inhibits T cell exhaustion and myeloid derived suppressor cell accumulation to promote anti-tumor immune responses in head and neck squamous cell carcinoma.
    Int J Cancer. 2019 Nov 10. doi: 10.1002/ijc.32781.
    PubMed     Abstract available
    
    
    October 2019
36. AVERSA J, Song M, Shimazu T, Inoue M, et al
    Prediagnostic Circulating Inflammation Biomarkers and Esophageal Squamous Cell Carcinoma: A Case-Cohort Study in Japan.
    Int J Cancer. 2019 Oct 31. doi: 10.1002/ijc.32763.
    PubMed     Abstract available
    
    
    
37. BECKHAM TH, Barney C, Healy E, Wolfe AR, et al
    Platinum-Based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32736.
    PubMed     Abstract available
    
    
    
38. LEONG MML, Cheung AKL, Kwok TCT, Lung ML, et al
    Functional Characterization of a Candidate Tumor Suppressor Gene, Mirror Image Polydactyly 1, in Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Oct 14. doi: 10.1002/ijc.32732.
    PubMed     Abstract available
    
    
    
39. MADATHIL S, Rousseau MC, Joseph L, Coutlee F, et al
    Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32708.
    PubMed     Abstract available
    
    
    
40. BETTAMPADI D, Villa LL, Lazcano Ponce E, Salmeron J, et al
    Oral Human Papillomavirus Prevalence and Type Distribution by Country (Brazil, Mexico and the United States) and Age among HPV Infection in Men (HIM) Study Participants.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32713.
    PubMed     Abstract available
    
    
    September 2019
41. KANO M, Kondo S, Wakisaka N, Wakae K, et al
    Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
    Int J Cancer. 2019;145:1547-1557.
    PubMed     Abstract available
    
    
    August 2019
42. TAN LP, Tan GW, Sivanesan VM, Goh SL, et al
    Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of Nasopharyngeal Carcinoma.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32656.
    PubMed     Abstract available
    
    
    
43. GANGKOFNER DS, Holzinger D, Schroeder L, Eichmuller SB, et al
    Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Int J Cancer. 2019 Aug 12. doi: 10.1002/ijc.32623.
    PubMed     Abstract available
    
    
    
44. KO JM, Ning L, Zhao XK, Chai AW, et al
    BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
    Int J Cancer. 2019 Aug 9. doi: 10.1002/ijc.32619.
    PubMed     Abstract available
    
    
    July 2019
45. ANUSIC T, Gianicolo EAL
    Comment on "A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma" by Islami et al.
    Int J Cancer. 2019 Jul 31. doi: 10.1002/ijc.32601.
    PubMed    
    
    
    
46. DIJKSTERHUIS WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, et al
    Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32580.
    PubMed     Abstract available
    
    
    
47. GIULIANO AR, Nedjai B, Lorincz AT, Schell MJ, et al
    Methylation Of Hpv 16 And Epb41l3 In Oral Gargles: Associations With Oropharyngeal Cancer Detection And Tumor Characteristics.
    Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32570.
    PubMed     Abstract available
    
    
    
48. DOVEY DE LA COUR C, Dehlendorff C, Aalborg GL, von Buchwald C, et al
    Use of nonaspirin non-steroidal anti-inflammatory drugs and risk of head and neck cancer: a nationwide case-control study.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32544.
    PubMed     Abstract available
    
    
    May 2019
49. SCHMITT K, Molfenter B, Koerich Laureano N, Tawk B, et al
    Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Int J Cancer. 2019 May 28. doi: 10.1002/ijc.32481.
    PubMed     Abstract available
    
    
    
50. DOGAN S, Xu B, Middha S, Vanderbilt CM, et al
    Identification of Prognostic Molecular Biomarkers in 157 HPV-positive and HPV-negative Squamous Cell Carcinomas of the Oropharynx.
    Int J Cancer. 2019 May 16. doi: 10.1002/ijc.32412.
    PubMed     Abstract available
    
    
    
51. RAMAYANTI O, Verkuijlen SAWM, Novianti P, Scheepbouwer C, et al
    Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Int J Cancer. 2019;144:2555-2566.
    PubMed     Abstract available
    
    
    
52. YOU R, Liu YP, Lin M, Huang PY, et al
    Relationship of Circulating Tumor Cells and Epstein-Barr Virus DNA to Progression-Free Survival and Overall Survival in Metastatic Nasopharyngeal Carcinoma Patients.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32380.
    PubMed     Abstract available
    
    
    April 2019
53. LEE VH, Kwong DL, Leung TW, Choi CW, et al
    The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
    Int J Cancer. 2019;144:1713-1722.
    PubMed     Abstract available
    
    
    March 2019
54. BISWAS NK, Das C, Das S, Maitra A, et al
    Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32305.
    PubMed     Abstract available
    
    
    
55. LIU CC, Chou KT, Hsu JW, Lin JH, et al
    High metabolic rate and stem cell characteristics of esophageal cancer stem-like cells depend on the Hsp27-AKT-HK2 pathway.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32301.
    PubMed     Abstract available
    
    
    
56. ISLAMI F, Poustchi H, Pourshams A, Khoshnia M, et al
    A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220.
    PubMed     Abstract available
    
    
    
57. LIU X, Song M, Wang P, Zhao R, et al
    Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32285.
    PubMed     Abstract available
    
    
    
58. YE F, Gao H, Xiao L, Ding H, et al
    Reply to Cirello et al. "Absence of the MAP2K5 germline variants c.G961A and c. T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families." International Journal of Cancer 2019; in press.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32243.
    PubMed    
    
    
    
59. CIRELLO V, Colombo C, Persani L, Fugazzola L, et al
    Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32244.
    PubMed    
    
    
    January 2019
60. TAN GW, Sivanesan VM, Abdul Rahman FI, Hassan F, et al
    A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32173.
    PubMed     Abstract available
    
    
    
61. NOVOPLANSKY O, Fury M, Prasad M, Yegodayev K, et al
    MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32170.
    PubMed     Abstract available
    
    
    
62. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    Fiber Intake and the Risk of Head and Neck Cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32162.
    PubMed     Abstract available
    
    
    
63. WU C, Nilsson K, Zheng Y, Ekenstierna C, et al
    Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs.
    Int J Cancer. 2019;144:297-310.
    PubMed     Abstract available
    
    
    
64. AL-SAHAF S, Hunter KD, Bolt R, Ottewell PD, et al
    The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
    Int J Cancer. 2019;144:334-344.
    PubMed     Abstract available
    
    
    
65. LI WF, Chen NY, Zhang N, Hu GQ, et al
    Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32099.
    PubMed     Abstract available
    
    
    December 2018
66. MENYA D, Maina SK, Kibosia C, Kigen N, et al
    Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case-control study and a pan-African perspective.
    Int J Cancer. 2018 Dec 23. doi: 10.1002/ijc.32086.
    PubMed     Abstract available
    
    
    
67. GRABER JM, Harris G, Black K, Lucchini RG, et al
    Excess HPV-related head and neck cancer in the World Trade Center Health Program General Responder cohort.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32070.
    PubMed     Abstract available
    
    
    
68. HUI KF, Chan TF, Yang W, Shen JJ, et al
    High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32049.
    PubMed     Abstract available
    
    
    November 2018
69. MATOBA T, Imai M, Ohkura N, Kawakita D, et al
    Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32024.
    PubMed     Abstract available
    
    
    
70. ZHANG Y, Tang LL, Li YQ, Liu X, et al
    Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32021.
    PubMed     Abstract available
    
    
    
71. FENG J, Zhao F, Sun J, Lin B, et al
    Alterations in the Gut Microbiota and Metabolite Profiles of Thyroid Carcinoma Patients.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32007.
    PubMed     Abstract available
    
    
    
72. REN S, Gaykalova D, Wang J, Guo T, et al
    Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2018;143:2425-2436.
    PubMed     Abstract available
    
    
    
73. SAHNANE N, Ottini G, Turri-Zanoni M, Furlan D, et al
    Comprehensive analysis of HPV infection, EGFR exon 20 mutations and LINE1 hypomethylation as risk factors for malignant transformation of sinonasal inverted papilloma to squamous cell carcinoma.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31971.
    PubMed     Abstract available
    
    
    October 2018
74. KASHIMA H, Noma K, Ohara T, Kato T, et al
    Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31953.
    PubMed     Abstract available
    
    
    
75. HUEBBERS CU, Verhees F, Poluschkin L, Olthof NC, et al
    Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31954.
    PubMed    
    
    
    
76. CUI M, Hu Y, Bi Y, Wang W, et al
    Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948.
    PubMed     Abstract available
    
    
    
77. HESARI A, Azizian M, Sheikh A, Nesaei A, et al
    Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31947.
    PubMed     Abstract available
    
    
    
78. SONG E, Oh HS, Jeon MJ, Chung KW, et al
    The value of preoperative anti-thyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 25. doi: 10.1002/ijc.31944.
    PubMed     Abstract available
    
    
    
79. JENDRZEJEWSKI J, Liyanarachchi S, Eiterman A, Thomas A, et al
    Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31933.
    PubMed     Abstract available
    
    
    
80. HUANG FQ, Li J, Jiang L, Wang FX, et al
    Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 14. doi: 10.1002/ijc.31925.
    PubMed     Abstract available
    
    
    September 2018
81. HUFBAUER M, Maltseva M, Meinrath J, Lechner A, et al
    HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Int J Cancer. 2018;143:1426-1439.
    PubMed     Abstract available
    
    
    
82. TAO Y, Sturgis EM, Huang Z, Sun Y, et al
    A TGF-beta1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Int J Cancer. 2018;143:1327-1334.
    PubMed     Abstract available
    
    
    
83. DUDDING T, Johansson M, Thomas SJ, Brennan P, et al
    Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization.
    Int J Cancer. 2018;143:1029-1036.
    PubMed     Abstract available
    
    
    August 2018
84. KAUPPILA JH, Wahlin K, Lagergren P, Lagergren J, et al
    Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31840.
    PubMed     Abstract available
    
    
    
85. YE F, Gao H, Xiao L, Zuo Z, et al
    Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31825.
    PubMed     Abstract available
    
    
    
86. MENYA D, Kigen N, Oduor M, Maina SK, et al
    Traditional and commercial alcohols and esophageal cancer risk in Kenya.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31804.
    PubMed     Abstract available
    
    
    
87. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Abstract available
    
    
    
88. OCK S, Ahn J, Lee SH, Kim HM, et al
    Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31779.
    PubMed     Abstract available
    
    
    July 2018
89. ROY R, Kandimalla R, Sonohara F, Koike M, et al
    A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31755.
    PubMed     Abstract available
    
    
    
90. CHEN X, Wang L, Li P, Song M, et al
    Dual TGF-beta and PD-1 blockade synergistically enhances MAGE-A3-specific CD8(+) T cell response in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31730.
    PubMed     Abstract available
    
    
    
91. JIANG C, Chen J, Xie S, Zhang L, et al
    Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31642.
    PubMed     Abstract available
    
    
    
92. PENG SY, Tu HF, Yang CC, Wu CH, et al
    miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31638.
    PubMed     Abstract available
    
    
    
93. ABRAHAO R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, et al
    The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
    Int J Cancer. 2018;143:32-44.
    PubMed     Abstract available
    
    
    June 2018
94. KO JM, Tsang KH, Dai W, Choi SSA, et al
    Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31617.
    PubMed     Abstract available
    
    
    April 2018
95. YU C, Guo Y, Bian Z, Yang L, et al
    Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31566.
    PubMed     Abstract available
    
    
    
96. MAZUL AL, Shivappa N, Hebert JR, Steck SE, et al
    Proinflammatory diet is associated with increased risk of squamous cell head and neck cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31555.
    PubMed     Abstract available
    
    
    
97. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31534.
    PubMed     Abstract available
    
    
    
98. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 12. doi: 10.1002/ijc.31426.
    PubMed     Abstract available
    
    
    
99. BEYNON RA, Lang S, Schimansky S, Penfold CM, et al
    Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from Head and Neck 5000, a prospective observational cohort of people with head and neck cancer.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31416.
    PubMed    
    
    
    March 2018
100. ARTHUR AE, Goss AM, Demark-Wahnefried W, Mondul AM, et al
     Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study.
     Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31413.
     PubMed     Abstract available
     
     
     
101. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
     Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
     Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
     PubMed     Abstract available
     
     
     February 2018
102. CHUNG YL, Wu ML
     Spatiotemporal homogeneity and distinctness of the T-cell receptor beta-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
     Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31336.
     PubMed     Abstract available
     
     
     
103. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
     Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
     Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
     PubMed     Abstract available
     
     
     
104. CHAN KKW, Saluja R, Delos Santos K, Lien K, et al
     Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis.
     Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31312.
     PubMed     Abstract available
     
     
     
105. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
     Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
     Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
     PubMed     Abstract available
     
     
     January 2018
106. WANG YQ, Chen YP, Zhang Y, Jiang W, et al
     Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.
     Int J Cancer. 2018 Jan 27. doi: 10.1002/ijc.31279.
     PubMed     Abstract available
     
     
     
107. LEEMAN JE, McBride SM, Spielsinger D, Sherman EJ, et al
     Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.
     Int J Cancer. 2018 Jan 25. doi: 10.1002/ijc.31277.
     PubMed     Abstract available
     
     
     
108. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
     Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
     Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
     PubMed     Abstract available
     
     
     December 2017
109. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
     Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
     Int J Cancer. 2017;141:2430-2436.
     PubMed     Abstract available
     
     
     
110. STANGL S, Tontcheva N, Sievert W, Shevtsov M, et al
     Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology
     Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213.
     PubMed     Abstract available
     
     
     November 2017
111. DOSSUS L, Franceschi S, Biessy C, Navionis AS, et al
     Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
     Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31172.
     PubMed     Abstract available
     
     
     
112. YUNHONG T, Jie L, Yunming T, Guoqian Z, et al
     Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
     Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31157.
     PubMed     Abstract available
     
     
     
113. HU J, Li H, Luo X, Li Y, et al
     The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
     Int J Cancer. 2017;141:1722-1729.
     PubMed     Abstract available
     
     
     October 2017
114. MAO L, Zhao ZL, Yu GT, Wu L, et al
     gamma-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
     Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31115.
     PubMed     Abstract available
     
     
     
115. HOFFMANN M, Pasch S, Schamberger T, Maneck M, et al
     Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
     Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31108.
     PubMed     Abstract available
     
     
     
116. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
     Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
     Int J Cancer. 2017;141:1355-1364.
     PubMed     Abstract available
     
     
     September 2017
117. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
     A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
     Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
     PubMed     Abstract available
     
     
     
118. LIU J, Lv L, Gong J, Tan Y, et al
     Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
     Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
     PubMed     Abstract available
     
     
     August 2017
119. SHIVAPPA N, Hebert JR, Rosato V, Garavello W, et al
     Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.
     Int J Cancer. 2017;141:471-479.
     PubMed     Abstract available
     
     
     June 2017
120. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
     Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
     Int J Cancer. 2017;140:2748-2757.
     PubMed     Abstract available
     
     
     April 2017
121. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
     Worldwide burden of cancer attributable to HPV by site, country and HPV type.
     Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: